AXIM Biotechnologies Receives Notice of U.S. Patent Allowance for Three Separate Patents Including Its R - Benzinga
| AXIM Stock | USD 0 0.0007 35.00% |
About 57% of all Axim Biotechnologies' investors are looking to take a long position. The analysis of overall sentiment of trading Axim Biotechnologies pink sheet suggests that some investors are interested at this time. Axim Biotechnologies' investing sentiment overview a quick insight into current market opportunities from investing in Axim Biotechnologies. Many technical investors use Axim Biotechnologies stock news signals to limit their universe of possible portfolio assets and to time the market correctly.
Axim Biotechnologies pink sheet news, alerts, and headlines are usually related to its technical, predictive, social, and fundamental indicators. It can reflect on the current distribution of Axim daily returns and investor perception about the current price of Axim Biotechnologies as well as its diversification or hedging effects on your existing portfolios.
Axim |
AXIM Biotechnologies Receives Notice of U.S. Patent Allowance for Three Separate Patents Including Its R Benzinga
Read at news.google.com
 |
Axim Biotechnologies Fundamental Analysis
We analyze Axim Biotechnologies' financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Axim Biotechnologies using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Axim Biotechnologies based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Return On Asset
Return On Asset Comparative Analysis
Axim Biotechnologies is currently under evaluation in return on asset category among its peers. Return on Asset or ROA shows how effective is the management of the company in generating income from utilizing all of the assets at their disposal. It is a useful ratio to evaluate the performance of different departments of a company as well as to understand management performance over time.
Axim Biotechnologies Potential Pair-trading
One of the popular trading techniques among algorithmic traders is to use market-neutral strategies where every trade hedges away some risk. Because there are two separate transactions required, even if one position performs unexpectedly, the other equity can make up some of the losses. Below are some of the equities that can be combined with Axim Biotechnologies pink sheet to make a market-neutral strategy. Peer analysis of Axim Biotechnologies could also be used in its relative valuation, which is a method of valuing Axim Biotechnologies by comparing valuation metrics with similar companies.
Peers
Axim Biotechnologies Related Equities
| RPID | Rapid Micro | 6.06 | ||||
| ICCM | Icecure Medical | 5.06 | ||||
| TIVC | Tivic Health | 4.00 | ||||
| SSKN | STRATA Skin | 3.96 | ||||
| TCMD | Tactile Systems | 3.22 | ||||
| BWAY | Brainsway | 1.96 | ||||
| SRDX | SurModics | 0.23 | ||||
| TNON | Tenon Medical | 2.14 | ||||
| BBLG | Bone Biologics | 3.17 | ||||
| VERO | Venus Concept | 5.88 |
Other Information on Investing in Axim Pink Sheet
Axim Biotechnologies financial ratios help investors to determine whether Axim Pink Sheet is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Axim with respect to the benefits of owning Axim Biotechnologies security.